SBIR/STTR Research Award

In situ assay for RNA decapping in tumors

Award identifier cd56222bd56ed43a4947ebe32ebbe0be7893096dd7aa33abb499bbe47f24557fAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$149,051

Program and phase

SBIR · Phase I

Award year

2018

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
VIVID TECHNOLOGIES INC
Proposal award date
2018-03-01
Contract end date
2020-02-29
UEI
DP9ZTZNNGDE7
Solicitation number
PA16-302
Topic code
102

Research abstract

In situ assay for RNA decapping in tumors Abstract This project aims to introduce a new histotechnology to assess tumor cell stress and cell death propensitywhich can be useful in evaluating cancer response to therapyThe adaptive response of tumor cells to stress and their survival in hostile environments are signaled by the levels of mRNA decayIncreased decay dumps important mRNAs and marks cells in distressConverselydecay blockage is highly protectiveIt stabilizes active mRNAs in cancer cellssupports metabolic stability and successful adaptation of the tumorThe major RNA destruction pathway ismRNA decayIts defining step is decappingwhich removes the Nmethyl guanosine cap fromRNA endsRNA decapping is the rate determining step and the best indicator of the decay activityAlthough mRNA decay is a key process in tumor survivalat present it cannot be imaged and assessed in tissue sectionsIn the absence of specific histotechnologiesit is currently studied by using bulk biochemical approaches which have limited value in heterogeneous pathology samplesIn this project we will overcome this obstacle and will develop a new and enabling technology for molecular analysis of tumor cellsWe will introduce the first assay for in situ assessment ofmRNA decay pathway via specific labeling of its decapping step in tissue sectionsThe project will create a new molecular histopathology tool and an advantageous product with wide applicability in studies of cancer and drug development where assessments of mRNA decay are essentialThe proposal will reach these Specific AimsTo develop the first methodology for selective detection of RNA decapping in tissue sectionsThe approach will label the key event of this pathway and visualize the characteristic RNA cleavage activity exposingterminal monophosphatesTo test and optimize the new labeling approach in tissue sections by using several models with active RNA decay reaction including glioblastomaTo validate the new assay specificity and ensure its adequate sensitivity and reliable robust detectionNarrative Statement The purpose of this project is to introduce an enabling method to analyze many varieties of cancerThis will produce a new and useful histological assay with broad commercial applications in the development of more efficient therapies and for molecular research in cancer and other pathologies where tissues sections are routinely used

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

8 SBIR/STTR records share this UEI (2007–2021). Reported award amounts total $1,557,288. Reported amounts are not federal obligations.

Phases: Phase I

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.